FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.5254
-0.0041 (-0.77%)
At close: Sep 17, 2025, 4:00 PM EDT
0.5300
+0.0046 (0.88%)
Pre-market: Sep 18, 2025, 7:50 AM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $22.01 million as of September 18, 2025. Its market cap has decreased by -61.23% in one year.
Market Cap
22.01M
Enterprise Value
23.94M
1-Year Change
-61.23%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $22.01M, a decrease of -97.67%. That is a compound annual growth rate of -90.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 22.18M | -68.39% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |